Surgical Treatment of Chronic Pancreatitis
Chromc pancreanns has an modence of 5 to 10 per 100,000 in the United States and is most commonly assocmted with chronic alcohol abuse (75%). The most common reason for patient presentanon is chromc pam, either persistent continuous pare or pare related to eating. Patients selected for surgical treatment of pare should have some demonstrable pancreanc anatomic abnormahty Panents with chromc pancreatms have an increased risk of developing pancreanc cancer compared to the general populanon.
SYMPTOMS AND DIAGNOSIS
The major dlsabhng symptom in panents with chronic pancreanns is pron. There is often assooated weight loss, and many pauents develop narconc dependency. Diabetes, maldlgesnon, and jaundice are also frequently seen.
The diagnosis of chronic pancreantas and its compllcanons is usually made by CT scan, ultrasonography, or endoscopic retrograde cholanglopancreatography (ERCP) Typical finchngs include a dilated pancreanc duct or "chain of lakes," pancreanc calclficanons, and pseudocysts Bfllary or duodenal obstrucnon or evidence of portal hypertension may also be found Dlstmgtushmg between chronic pancreantas and pancreauc cancer may be difficult, parucularly in panents without pancreauc calcification Marked elevanon of the serum CA 19-9 level in a nonjaundlced patient is tughly suggesnve of pancreanc cancer ERCP delineates the pancreauc and blhary ductal anatomy and is important in determlmng which panents rmght benefit from surgery and for plannmg the most appropriate operation. In panents with atypical gastrointestinal bleeding and pancreanns, angaography of the cehac and superior mesentenc arteries is indicated to detect and embohze pseudoaneurysms.
In adchuon to assessmg the pathologac anatomy of the pancreas, it is lmpo~nt to establish a baseline for pancreatic exocnne and endocrine function, nutrlnonal status, pain seventy, analgesia usage, employment status, and quahty of hfe. Any problems revolving continued alcohol or narconc use need to be addressed as part of both surgical or nonsurgacal management programs TREATMENT Patients with disabling abdominal pain and evidence of chronic pancreatatas who have pancreatac ductal dlsruptaon or obstructaon with upstream dllatanon are most hkely to benefit from operanve mtervennon. Such panents are best managed by surgacal cyst or ductal decompression or resecnon. Panents with chromc pancreanns and bile duct obstrucnon require bihary-entenc decompression Although preservation of pancreatic tissue is desirable to maintain both exocrme and endocnne function, there are sltuauons m which pancreanc resecuon is the preferred treatment. Alternauve procedures such as endoscopic sphlncterotomy, short-term stent placement m the major pancreanc duct or pancreatic pseudocyst, and extracorporeal shock wave hthotnpsy for stones may provide relief of symptoms on a short-term basis, but are less effecnve in the long term
RISKS
The risks associated with operations for chronic pancreatans and its comphcations include mfectaon, bleedmg, blhary and pancreanc anastomlc leaks, and acute pancreanns The frequency of these comphcanons ranges from 0.5% to 5% The mortahty rate for pancreatac surgery varies with the procedure and is generally less than 5% for major resecnons and lower for nonresecuve operanons EXPECTED OUTCOMES Good pain rehef can be expected in 75% to 80% of pauents lmtlally and will be sustained m most patients for 3 to 5 years. The incidence of postoperauve diabetes and steatorrhea is a reflecnon of the amount of parenchyma resected and the disease stares of the residual gland The natural progression of exocnne and endocnne insufficiency associated with chronic pancreatms exacts an addmonal toll of 10% to 15 % of nondiabenc patients becoming diabetic within a decade. Abstinence from alcohol and decompression of an obstructed main ductal system may slow the progression of exocnne and endocrine insufficiency in some panents but will not prevent their occurrence. A~er surgery most panents experience weight gain The best outcomes occur in panents who abstain from alcohol and narcoucs and are compliant with pancreanc enzyme replacement regimens
The average length of stay after major pancreanc surgical procedures is 12 to 16 days, and tends to be longer after pancreatacoduodenectomy than after dis- 
